Abstract
Undifferentiated spondyloarthropathies USPA can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor TNF-alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment.
- Copyright: © Saudi Medical Journal
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Jump to section
Related Articles
Cited By...
- No citing articles found.